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Abstract
Background: Canine influenza virus (CIV) and Staphylococcus pseudintermedius (Sp) are pathogens that cause
respiratory disease in dogs. Considering bacterial infections following influenza are a leading cause of illness and
death, it is of particular meaning to investigate the interaction between these two pathogens. In this study, BALB/c
mice were used as a mouse model to assess whether inoculation with CIV H3N2 followed by S. pseudintermedius 72
h later resulted in exacerbation of disease. Disease was characterized by assessment of body weight loss, titration of
virus and bacteria, histopathology, and cytokine production.
Results: There was a significantly greater decrease in body weight in the co-infected group compared with the
CIV-only and SP-only groups. CIV inoculation increased bacterial colonization, whereas secondary infection with S.
pseudintermedius elevated the viral RNA load of CIV in tissues. The histological lesions in the brain, spleen and lung
were more severe in the CIV/Sp group than in the singly treated groups. Infection with CIV alone, Sp alone or
coinfection stimulated a significantly higher release of cytokines, such as interferon-gamma (IFN)-γ, interleukin 6 (IL)
-6, tumor necrosis factor (TNF-α) and lymphotactin (Lptn), than was observed in the mock-infected group (PBS).
Moreover, the levels of IFN-γ in the spleen and lung were higher in the CIV/Sp group compared with the CIV-only
and Sp-only groups.
Conclusion: Our findings provide the first demonstration that the secondary infection of mice with Sp leads to
increased clinical signs and lesions during canine influenza.
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Background
Canine infectious respiratory disease (CIRD) is a common,
worldwide disease syndrome, and involves a number of
viral and bacterial pathogens. Canine influenza virus (CIV)
is one of the viral causes of contagious respiratory disease
[1]. In January 2004, CIV subtype H3N8 was first reported
in racing greyhound dogs in Florida [2]. Subsequently, in
2007, a different influenza virus, subtype H3N2, caused an
outbreak of canine respiratory disease in South Korea [3].
Recent reports suggest that H3N2 CIV has become en-
demic in the canine populations in China [4–6].
Bacterial pathogens associated with CIRD include
Bordetella bronchiseptica, Streptococcus equi subspecies
zooepidemicus and Mycoplasma [7]. In humans,
Staphylococcal species are frequently identified as the
cause of bacterial pneumonia [8, 9]. A study from our
group showed that Staphylococcus pseudintermedius
(Sp) was the most frequently isolated bacterial pathogen
(24/40) from respiratory cases (unpublished data). This
bacterium has been previously misidentified as S. inter-
medius. The name S. pseudintermedius is now given to
the canine-specific strain of S. intermedius [10]. S. pseu-
dintermedius is a common commensal of oral and nasal
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vacities and the skin in healthy dogs, where it can also
cause invasive disease [11, 12]. Sasaki et al. [13] isolated
Sp from inpatient dogs (46.2 %) and outpatient dogs
(19.4 %) in a Japanese veterinary teaching hospital. Some
recent reports confirmed this bacterium can spread from
pets to their owners [14, 15] and to the veterinary staff
working in the veterinary clinics [16]. Furthermore,
methicillin resistant S. pseudintermedius (MRSP) has
emerged as an increasingly important cause of oppor-
tunistic infections in dogs [17]. It may emerge as a major
and difficult-to-treat pathogen in the future.
In humans, co-infections of influenza virus and re-
spiratory bacterial pathogens are common, and bacterial
secondary infections have played an important role in
influenza virus pandemics [18, 19]. Influenza pneumonia
occurs mainly due to virus-bacteria interactions because
of a synergistic effect that occurs during invasion of the
respiratory tract [20]. Epithelial and mucosal degradation
occurs due to viral replication, resulting in a reduced in-
nate immune response to prevent secondary bacterial in-
fections [21]. Thus, bacterial infections may be the main
cause of death related to influenza virus infection in the
absence of a pre-existing co-morbidity [22, 23].
Although CIV infection is typically self-limited with
high-morbidity but low mortality, co-infections with re-
spiratory bacterial pathogens may impact the pathogen-
icity and course of disease. It will be of particular
importance considering the role of secondary bacterial
infections as a major complication of influenza in pet
clinics. To understand the treatment procedures for
fighting viral and secondary bacterial infections, it is im-
portant to study the mechanisms involved in the inter-
action between influenza virus and bacterial organisms.
In the present study, we investigated the interactions be-




The viral strain A/Canine/Jiangsu/06/2010 (H3N2) was
used in this study. The viral strain was isolated from
nasopharyngeal swabs of dogs with severe respiratory
syndrome, which were collected from Animal Clinics of
Nanjing Agricultural University in Jiangsu Province of
China in 2010. The GenBank accession numbers are
JN247615 to JN247623. Plaque assays were performed
on monolayers of Madin-Darby canine kidney (MDCK)
cells in 12-well tissue culture plates to determine the
viral titres [24]. Viral aliquots were diluted in phosphate-
buffered saline (PBS) supplemented with 0.1 % bovine
serum albumin and adjusted to a final concentration of
1x105 plaque forming units (PFU)/ml [25]. The Sp NJ-1
strain was isolated from a dog with respiratory syn-
drome. The bacterial species was identified based on its
biochemical characteristics [26] and sequencing of the
16S rRNA gene. To prepare the inoculum, the bacterial
strain was cultured in Luria–Bertani (LB) broth at 37 °C
for 4 h. A suspension with approximately 1x109 colony
forming units (CFU)/ml was made in phosphate-
buffered saline (PBS).
Mice
BALB/c mice (6 weeks of age, 18–20 g) were purchased
from the Animal Experiment Centre, Yangzhou University,
China. All of the mice were housed in individual compart-
ments in stainless-steel wire cages. Before conducting the
study, approval for conducting the experiments was
obtained from the Animal Ethics Committee of Nanjing
Agricultural University.
Animal experiments
One hundred mice were randomly divided into four
groups with 25 mice per group. The mice in group 1
(Sp-only) were intranasally inoculated with Sp(1×109
CFU/ml, 50 μl/mouse) and 72 h later inoculated with
non-infectious MDCK cell culture supernatant (50 μl/
mouse); the mice in group 2 (CIV-only) were intrana-
sally inoculated with PBS (50 μl/mouse) and 72 h later
inoculated with CIV (1×105 PFU/ml, 50 μl/mouse); the
mice in group 3 (CIV/Sp) were intranasally inoculated
with CIV and 72 h later inoculated with Sp; and the mice
in group 4 were inoculated with non-infectious MDCK
cell culture supernatant and 72 h later inoculated with
PBS. The groups were housed in individual isolation
rooms.
The daily weight and clinical signs were recorded for up
to five days. The observers were blinded as to the experi-
mental treatments and they had veterinary medical qualifi-
cations to make assessments about clinical signs. Three
mice from each group were killed humanely according to
a pre-designated schedule at indicated time points. Blood
samples from the experimental groups were collected
using sodium heparin tubes from the eyeball capillary be-
fore collecting tissues, including spleen, lung and brain, at
1, 2, 3, 4 and 5 days post-infection (d.p.i.).
Pathological analysis
The lung, spleen and brain tissues from mice belonging to
the various groups were harvested at 2 days post Sp chal-
lenge in the co-infected group and were fixed in 10 % for-
malin. After fixation, the tissues were embedded in paraffin
wax. Tissue sections with a thickness of 4 μm were stained
with haematoxylin and eosin (H&E) and assessed for the
degree of inflammation and necrosis. The lungs were
assigned a grade 0 to 3 based on the histological character-
istics as described by Alymova et al. [27]. A score of 0 was
given when no pathological changes could be detected. A
score of 1 was given to findings representing mild
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pathologies, including minimal infiltrates of lymphocytes
and plasma cells around airways and vessels, minimal epi-
thelial hyperplasia, minimal leukocyte infiltration of alveolar
spaces, and <10 % of the lung affected. A score of 2 was
given for findings representing moderate pathologies, in-
cluding moderate infiltrates of lymphocytes and plasma
cells around airways and vessels, moderate epithelial hyper-
plasia with focal necrosis, focally extensive infiltration of
the alveolar spaces by leukocytes with some consolidation,
focal pleuritis, and >10 % but <30 % of the lung affected. A
score of 3 was given for findings representing pathologies
of greater severity, including extensive necrosis of airway
epithelium and of interstitium, extensive leukocyte infiltra-
tion and consolidation, severe pleuritis, and lobar involve-
ment. Grading and descriptions of pathology were
performed by an experienced veterinary pathologist in a
single-blinded manner.
Bacterial isolation
Samples of lung, spleen and brain from each mouse
were weighed and homogenized individually in PBS to
obtain a 10 % weight-to-volume suspension. The num-
ber of CFUs of Sp was determined by plating serial 10-
fold dilutions of homogenates or blood on LB agar in
duplicate. Therefore, the results are reported as CFU/ml
for blood and as CFU/g for the lung, spleen and brain.
Determination of viral loads
The tissues were homogenized in lysates at a ratio of 1:1
(g/ml) and centrifuged at 10,000 g for 30 min, and the
supernatants were collected for viral RNA extraction
using a Virus Nucleic Acid Extraction Kit II (Geneaid,
Taiwan). Quantitative RT-PCR (RT-qPCR) was performed
to measure the viral loads in the above-mentioned or-
gans and blood samples. The RNA from the samples
was reverse-transcribed and run in an ABI 7300 Real-
time PCR System using a SYBR1 Premix Ex Taq™ (Per-
fect Real Time) kit (TaKaRa, Dalian). The following
primers were designed and used on the matrix gene
region: 5′-TCTATCGTCCCATCAGGC/GGTCTTGT
CTTTAGCCATTC-3′. Simple Vector pMD19-T (50
ng/μl; TaKaRa, Dalian) containing the target virus
sequence was used as a reference standard. Series of
eight 10-fold dilutions equivalent to 1×103-1×1010
copies per reaction were prepared to generate calibra-
tion curves and were run in parallel with the test sam-
ples [28].
Quantification of cytokine levels
The cytokine level was assessed to determine the correl-
ation between severe disease and inflammatory cytokine
production in the mice. The spleen and lung from the
mice in all of the groups were homogenized in 1 ml of
PBS/1 g of tissues. The homogenates were centrifuged,
and the supernatants were frozen at −70 °C until testing.
ELISAs for the levels of interferon-gamma (IFN-γ), inter-
leukin 6 (IL-6), lymphotactin (Lptn) and tumor necrosis
factor (TNF-α) on the lung and spleen from infected mice
were performed using ELISA kits (Sigma-Aldrich, Beijing)
according to the manufacturer’s instructions.
Statistical analysis
The data were collected and analysed using MS Excel
2010 and SPSS Statistics v20.0 software. The weight loss/
gain, bacterial load, viral load and cytokine levels were
analysed by analysis of variance (ANOVA) followed by
Turkey’s multiple comparison test [29, 30]. Differences
with P<0.05 were considered statistically significant, and
differences with P<0.01 were considered highly significant.
Results
Clinical signs during experimental infection in the mice
The mice showed normal features after bacterial inocu-
lation, but after 18 h post-infection (h.p.i), all the in-
fected mice manifested with lethargy, anorexia, huddling
and ruffled fur. It is notable that nervous signs appeared
in the mice of SP (2/25) and CIV/Sp (4/25) groups at 20
h.p.i. On 2 d.p.i., this phenomenon was more pro-
nounced. Distinct central nervous disturbances, includ-
ing bending of their head towards one side and walking
in circles, were observed in the Sp and CIV/Sp groups.
More severe clinical signs were observed in the CIV/Sp
group when the mice were lifted by the tail. Such neuro-
logical signs lasted until the end of experiment. But the
number of affected mice did not increase. Mice with
neurological signs lost more body weight compared with
the other mice in the same group. In contrast, the mice
in the CIV group did not show any neurological signs,
but the signs, such as depression, decreased activity,
huddling and ruffled fur, were witnessed in all the in-
fected mice from 24 h.p.i., and lasted until the end of
experiment
Body weight changes in mice
All of the infected groups exhibited a lowered body weight
compared with the PBS group (Fig. 1, Additional file 1).
Mice inoculated with virus alone showed mild to modest
disease severity. There was a significant difference
(P<0.05) between the sham and CIV groups only at 4 and
5 d.p.i. In contrast, Sp-alone-inoculated mice showed
signs of more severe illness, and there was a significant
difference between the sham and Sp groups (P<0.001) at
each time point. Significant differences were also observed
between the sham and CIV/Sp groups (P<0.001) at each
time point. Mice coinfected with CIV and Sp lost more
body weight compared with the mice in both the CIV-
only (P<0.001) and Sp-only (P<0.05 or P<0.01) groups at
2, 3, 4 and 5 d.p.i., indicating that mice coinfected with
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CIV followed by S. pseudintermedius developed more se-
vere disease.
Determination of viable bacteria and viral RNA loads in
the tissues of infected mice
The bacterial loads in the blood, brain, spleen and lungs of
mice infected with bacteria alone and with both virus and
bacteria were compared (Fig. 2, Additional file 1). At each
time point, the bacterial load in all of the tissues of the
coinfected group was relatively higher than that in the bac-
teria- alone group, but the statistically significant differences
were not necessarily found in each tissue. At 1 d.p.i., the
bacterial load in the blood, lung and brain was slightly
higher in the CIV/SP group compared with that in the Sp-
only group, but the difference was not significant (P>0.05).
However, the bacterial loads in the spleen showed signifi-
cantly higher level in the CIV/Sp group than in the Sp-only
group (P<0.01). At 2 d.p.i., the bacterial loads in the blood,
brain, spleen and lung had reached a peak level, and
showed a significant higher level in the blood, spleen and
lung of the coinfection group compared to the SP-lonely
group (P<0.05 or P < 0.01). At 3 d.p.i., bacterial load was
significantly higher in the spleen of CIV/Sp group than that
in the SP-lonely group (P<0.01), and at 5 d.p.i., the bacterial
loads in the blood, brain, spleen and lung were decreased
to more than 102, 105, 104 and 104 CFU/g (CFU/ml) in
both the two groups, respectively.
RT-qPCR was used to measure the viral loads in the
above tissues of mice infected with virus alone and with
both virus and bacteria (Fig. 3, Additional file 1). At all
time-points that virus was detected at, the viral load in all
the tissues of the coinfected group was higher than that in
the virus-alone group. Statistically, compared to CIV-only
group, the viral loads in the blood was significantly higher
at 3, 4 and 5 d.p.i. in the CIV/Sp group. The brain showed
more significant changes. At each time point, brain viral
loads in the CIV/Sp group were higher. The viral loads in
the CIV/Sp group showed significantly higher levels in the
spleen at 4 d.p.i. and in the lung at 2 d.p.i than those in
CIV-only group.
Histopathology
The extent of histological lesions in the brain, spleen
and lungs of mice infected with CIV/Sp and with either
Sp or CIV alone was compared at 2 d.p.i. All of the
tissues tested in the Sp-only, CIV-only and CIV/Sp
groups showed significant lesions, whereas the mice in
the PBS group showed no lesions in the lungs, brain and
spleen (Fig. 4).
The brain of the mice in the CIV-only group exhibited
the dissolution of nerve fibres. In some areas, a diffused
hyperplasia of microglial cells was noticed. In addition, the
disintegration of neuronal cells was observed (Fig. 4a). The
brain of the mice in the Sp-only group showed dissolution
of a large area of nerve fibres. The microglial cells were se-
verely diffused. The characterizing feature of the Sp group
was the appearance of vascular cuff and neurophagia phe-
nomena (Fig. 4b). Microscopic lesions in coinfected mice
included changes seen in mice infected with single agents,
but tended to be more severe than in mice infected with ei-
ther agent alone. The nerve fibre dissolution observed in
the CIV/Sp group was more obvious compared with that in
the other two groups, and the disappearance of neurons
was also observed (Fig. 4c). The spleen in the CIV-only
group did not present any lesions (Fig. 4e). Histopatho-
logical lesions in spleens from Sp-infected mice were char-
acterized by marked accumulations of macrophages, which
expanded marginal zones, and there was hyperplasia of the
lymphoid tissue in the spleen trabeculae (Fig. 4f). But the
lesions in the spleens from the CIV/Sp group (Fig. 4g)
Fig. 1 Changes in the body weights of BALB/c mice that were infected with CIV or S. pseudintermedius alone, coinfected with both, or exposed to PBS
as a control. The percentage of the body weight was calculated relative to the body weights recorded five days post-challenge. Analysis of variance
(ANOVA) was performed for the statistical analysis. ***, P < 0.001, indicates a significantly different weight percent for CIV groups compared with CIV/
Sp groups. #, P < 0.05, ##, P < 0.01, or ###, P < 0.001, indicates a significantly different weight percent for Sp groups compared with CIV/Sp groups
Kalhoro et al. BMC Veterinary Research  (2016) 12:87 Page 4 of 11
tended to be more pronounced than those in the Sp-only
group. The lung of the mice in the CIV-only group revealed
widening of the pulmonary interstitial and lung congestion
(Fig. 4i). Microscopic lesions of the lung of mice infected
with Sp alone typically consisted of multifocal areas of
moderate to severe interstitial thickening of alveoli with
mononuclear cells (Fig. 4j). The CIV/Sp group showed
similar lung congestion but severe fibrin exudation along
with accumulations of neutrophils in the bronchi and wid-
ened alveolar septa (Fig. 4k).
The histopathological scores for the H&E sections of the
lungs from mice were determined (Fig. 5, Additional file 1).
The histopathological score given to the lungs of the mice
in the CIV/Sp group was significantly higher than those of
the CIV group (P<0.01) and the Sp group (P<0.05).
Determination of cytokine concentrations
The levels of IFN-γ, TNF-α, IL-6 and Lptn in the
spleen and lung of mice at 1, 3 and 5 d.p.i. were
measured by ELISA (Fig. 6, Additional file 1). The
levels of all four cytokines in the spleen and lung were
elevated in the CIV-only, Sp-only and CIV/sp groups
compared with the PBS group. The most pronounced
difference was found at 3 d.p.i.. There were significant
values (P<0.01 or P<0.05) between the three infection
groups and the control group with the exception of
the IFN-γ and IL-6 levels in the spleen between the
Sp-only and PBS group and the TNF-α levels of the
lung between the CIV-only or CIV/Sp group and the
PBS group.
Compared with the CIV-only and Sp-only groups, at
1, 3 and 5 d.p.i., the levels of IFN-γ in the spleen and
lung were higher in the CIV/Sp group, and IFN-γ level
of the spleen reached the statistical significance at 1
d.p.i. (P < 0.01 or P < 0.05). At 1 d.p.i., the IL-6 levels
of the spleen and lung showed a significant difference
between the Sp and PBS groups. At 5 d.p.i., the IL-6
levels of the spleen in the Sp-only group were signifi-
cantly higher compared with the levels in the CIV-
only and CIV/Sp groups (P<0.01 or P<0.05), whereas
there was no significant difference in the IL-6 levels in
the lung between either the Sp-only or CIV-only
Fig. 2 Dynamic change in the bacteria loads in the blood, brain, spleen and lung (a, b, c and d) of mice infected with S. pseudintermedius alone
or both S. pseudintermedius and CIV. The bacterial loads in the infected animals were measured on days 1, 2, 3, 4 and 5 post-challenge. The results
are expressed as the mean log10 cfu/ml or log10 cfu/g. Each data point represents a single mouse, and the bar indicates the average for the
group. Analysis of variance (ANOVA) was performed for the statistical analysis. *, P < 0.05, **, P < 0.01, or ***, P < 0.001
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group and the CIV/Sp group. In the case of TNF-α
and Lptn, at 1 and 5 d.p.i., the highest levels in the
spleen were observed in the Sp-only group, whereas
the highest levels in the lung were found in the CIV-
only group. There was no significant difference be-
tween the Sp-only or CIV-only group and the CIV/Sp
group.
Discussion
Several studies have reported that influenza virus A is
extremely contagious to humans and domestic animals, in-
cluding avian, swine, equine, canine and feline species [31],
and causes significant losses to animals and humans. Infec-
tion with influenza virus alone is rarely fatal but can en-
courage secondary bacterial infections that lead to death
[32]. Sp is a common commensal in dogs and can cause op-
portunistic infections [33]. In this study, the coinfection of
CIV and Sp resulted in more severe clinical signs and body
weight loss in mice and an increased severity of micro-
scopic lesions in the brain, spleen and lung compared with
infection with either pathogen alone. The findings of this
study showed that the interaction between the two
pathogens appears to generate a more severe outcome than
that observed with the individual pathogens by themselves.
Our study demonstrated increased bacterial loads in the
blood, brain, spleen and lung of the mice in the CIV/Sp
group compared with those in the Sp-only group. The find-
ing is in agreement with observations from an earlier study
conducted by Lee et al. [25] in which mice co-infected with
virus and bacteria showed a higher bacterial load in the
blood, spleen, kidneys and liver at 4 and 72 h after staphylo-
coccal infection compared with the mice infected with bac-
teria alone. In another study, mice exposed to influenza
virus followed by S. pneumoniae showed greater bacterial
counts after 24 and 48 h of infection [34]. The nature of
the interaction between CIV and Sp is unknown. However,
studies have shown that influenza A virus infection leads to
increased susceptibility of the host to secondary bacterial
infection by damaging the respiratory epithelial barrier, up-
regulating host expression of receptors for bacteria, and
impairing the innate immune response [35, 36]. Bacterial
clearance can be prevented by viral-induced abnormalities
in the immune response [37–39]. Previous data suggest that
the increased bacterial titres in the lungs, blood and
Fig. 3 Dynamic change in the viral loads in the blood, brain, spleen and lung (a, b, c and d) of mice infected with CIV alone, or both S.
pseudintermedius and CIV. The viral loads in the infected animals were measured on days 1, 2, 3, 4 and 5 post-challenge. The results are expressed
as the log10 RNA copy numbers per gram or per millilitre of sample. Each data point represents a single mouse, and the bar represents the aver-
age for the group. Analysis of variance (ANOVA) was performed for the statistical analysis. *, P < 0.05, **, P < 0.01, or ***, P < 0.001
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secondary organs cause high mortality and morbidity in
groups of mice co-infected with S. aureus 3 and 7 d after
influenza virus A infection [29]. However, in the present
study, no mortality was noted; this finding may be because
CIV H3N2 is not lethal to mice [5, 6].
The present study showed that the bacterial loads in
the blood, brain, spleen and lungs peaked in Sp-only and
CIV/sp groups on d.p.i. 2, indicating that the bacteria
can enter the bloodstream, are transported to the other
tissues and then pass through the blood–brain barrier
into the brain, thus causing severe neurological signs.
Distinct central nervous disturbances observed at this
time, including bending of the head towards one side
and walking in circles, support this hypothesis. More se-
vere neurologic signs were observed in the coinfection
group. Interestingly, in addition to an increased bacterial
burden, we found that the viral loads in the blood, brain,
spleen and lung were augmented following bacterial in-
fection. Smith et al. [40] used a kinetic model to explore
the coupled interactions of influenza A virus and S.
pneumoniae and reported that the subsequent S.
Fig. 5 Degree of lung injury present in mice after infection with CIV
alone, S. pseudintermedius alone, or both. The lungs were assigned a
grade from 0 to 3 based on the histological character of the lesions.
Analysis of variance (ANOVA) was performed for the statistical
analysis. *, P < 0.05, or **, P < 0.01
Fig. 4 Histopathological lesions at 2 days post Sp challenge in the co-infected group, shown by H&E staining in the brain, spleen and lung of
mice infected with CIV alone, S. pseudintermedius alone, or both. a Representative brain image from the CIV-only group, showing diffused hyperplasia of
microglial cells and disintegration of neuron cells (400×). b Representative brain image from the Sp-only group, showing dissolution of nerve fibres, vascular
cuff phenomena and neurophagia phenomena (400×). c Representative brain image from the CIV/Sp group, showing nerve fibre dissolution and
disappearance of neurons (400×). e Representative spleen image from the CIV-only group, showing no lesions (100×). f Representative spleen image from
the Sp-only group, showing hyperplasia of the splenic trabeculae (100×). g Representative spleen image from the CIV/Sp group, showing hyperplasia and
degeneration of the splenic trabeculae (100×). i Representative lung image from the CIV-only group, showing widening of the pulmonary interstitial
(100×). j Representative lung image from the Sp-only group, showing widening of the alveolar septa (100×). k Representative lung image from the CIV/Sp
group, showing severe fibrin exudation, appearance of neutrophils and widening of the alveolar septa (100×). d, h, l Representative brain, spleen and lung
images of the control group, showing no histopathological lesions (400×, 400× and 100×)
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Fig. 6 Characterization of IFN-γ (a, e), IL-6 (b, f), TNF-α (c, g) and Lptn (d, f) secretion from the spleen (a, b, c and d) and lung (a, b, c and d)
tissues of mice after CIV alone, S. pseudintermedius alone, or both. The concentrations in the supernatants of homogenates from the spleens and
lungs on days 1, 3 and 5 post-challenge were measured by ELISA. The results are expressed in terms of pg/ml. Analysis of variance (ANOVA) was
performed for the statistical analysis. *, P < 0.05, **, P < 0.01, or ***, P < 0.001
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pneumoniae infection enhances viral release from in-
fected cells. Therefore, we speculate that the observed
increase in viral loads after bacterial infection may be
due to increased virus release via bacterial proteases.
Additionally, we cannot rule out the possible mechanism
that elevated viral loads in the presence of bacteria are
due to a reduction in viral clearance. Further work is ne-
cessary to study the precise mechanism involved.
The loads of both CIV and Sp in the coinfected mice
were greater compared with those of singly infected mice.
These results may help explain the increased severity of the
lesions observed in the coinfected mice. Additionally, cyto-
kine production after infection likely plays a role in the
pathological changes observed during infection. A previous
study reported that an excessive production of TNF-α leads
to immunopathology [41]. The study conducted by Lee et
al. [42] reported that the levels of IFN-γ and TNF-α in the
lungs of dogs infected with H3N2 influenza virus increased
rapidly, and the infected dogs developed severe bronchoin-
terstitial pneumonia accompanied by a massive infiltration
of immune cells. Lymphotactin is a chemokine that recruits
T and NK cells, and can regulate or modulate T cell–medi-
ated immune responses [43]. A previous report showed
mycobacterial antigen could induce an increase of Lptn
transcript, while Lptn has a regulation role in IFN-γ pro-
duction [44]. A study from van Berke [45] reported that a
gamma herpesvirus selective chemokine binding protein
could inhibit Lptn action. In the present study, we deter-
mined the concentrations of IFN-γ, IL-6, TNF-α and Lptn
in the lungs and spleen of mice infected with Sp alone, CIV
alone or both CIV and Sp. In general, higher levels of cyto-
kines were observed in all of the infection groups compared
with the uninfected animals. We speculated that elevated
levels of cytokines may be associated with the clinical mani-
festations observed in the infected mice. The comparison
among the three infection groups revealed that IFN-γ
showed the largest changes in the coinfected mice com-
pared with the mice infected with either agent alone, par-
ticularly on day 1. These data are consistent with previous
reports in which a higher level of IFN-γ expression was ob-
served after coinfection with influenza virus and bacteria
[25, 46]. IFN-γ is a Th1 cytokine that can activate macro-
phages to produce nitric oxide and other inflammatory me-
diators [47]. This finding may explain the increased severity
of lesions observed early in the coinfected mice compared
with the mice infected with bacteria or virus alone. With
the exception of IFN-γ, the other cytokine or chemokine
levels observed in coinfected mice showed no significant
differences from those observed in mice infected with CIV
or Sp alone. These data showed that coinfection did not in-
fluence the production levels of IL-6, TNF-α and Lptn.
Although mice are extensively used for influenza re-
search, and they can be successfully infected with CIV
[5, 6], the use of mouse model can be limited, however,
due to the fact that mice are not natural hosts for CIV.
The signs including lethargy, anorexia and body weight
loss, huddling and ruffled fur, which are characteristic of
influenza virus infection in mice [48], could be seen.
However, some signs in dog disease such as coughing,
nasal discharge and fever have not been observed. In the
future study, we will further perform coinfection of CIV
and Sp in beagles.
Conclusions
Taken together, the findings presented in this study showed
that coinfection with CIV and Sp may worsen clinical signs
and lesions in mice. This additive effect supports the need
for improving the current strategies for the control of influ-
enza and secondary bacterial infection. Because CIV is a
relatively recently described canine pathogen, the available
clinical data are relatively limited, and further epidemio-
logical studies on the interactions between this virus and
secondary bacterial infection are required.
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